Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, restricting access to the entry and its details. Navigation and site chrome remain visible, but the study content is inaccessible.SummaryDifference19%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a software update without changes to the study information.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, updating the page's revision metadata. This update does not change the study content or user-facing information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4. This reflects a newer version of the study record without altering content.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, reflecting a new page/document revision in the system. This appears to be a metadata/versioning update rather than a substantive content change on the study details.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a minor update to the page version; no substantive study content is affected.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.